COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Hematology
Reference57 articles.
1. Four-fold increased mortality from sars-Cov-2 infection in patients with hematologic versus non-hematologic malignancies treated at the largest tertiary COVID-19 center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020).;Yun;Blood,2021
2. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.;Vijenthira;Blood,2020
3. Outcomes of COVID-19 in patients with CLL: a multicenter international experience.;Mato;Blood,2020
4. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.;Scarfò;Leukemia,2020
5. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.;Chatzikonstantinou;Leukemia,2021
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of infections for patient treated with ibrutinib in clinical practice;Frontiers in Oncology;2024-09-10
2. Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia;Annals of Hematology;2024-07-15
3. Prevention and management of infectious complications in patients with chronic lymphocytic leukemia (CLL) treated with BTK and BCL-2 inhibitors, focus on current guidelines;Blood Reviews;2024-05
4. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States;International Journal of Cancer;2024-02-09
5. Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial;The Lancet Oncology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3